• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Omeros (OMER) Stock Dropped, So What Is Driving Attention Now?

    Simply Wall St·11/02/2026 08:27:31
    Listen to the news

    Omeros (OMER) has drawn fresh attention after its recent share performance, with the stock closing at $18.44 and showing a mix of short term swings and stronger multi year total returns.

    Omeros has seen momentum build over the past quarter, with a 90 day share price return of 46.82%. The latest session closed down 2.69% at $18.44, and the 30 day share price move is only slightly higher at 0.91%.

    Spot fresh momentum in Omeros, and then scan a curated set of other potential breakouts across biotech and beyond through the 19 high quality undiscovered gems.

    Omeros now pairs a long running drug pipeline story with a sharp 90 day share price jump. The real test is whether that business profile is already fully reflected in an $18.44 quote.

    Most Popular Narrative: 33% Undervalued

    Against the last close at $18.44, the most followed narrative pegs fair value at $27.50, which frames Omeros as materially discounted on its own cash flow and earnings path using a 7.24% discount rate.

    The expected closing of the Novo Nordisk transaction, with US$240 million upfront and up to US$2.1 billion in total potential consideration plus royalties, would remove near term debt obligations and extend the cash runway. This could ease funding risk and support future revenue and earnings growth from the remaining pipeline.

    See why 3 investors see Omeros as 33% undervalued.

    Result: Fair Value of $27.50 (UNDERVALUED)

    Still, the Omeros narrative leans heavily on timely YARTEMLEA approvals and the Novo Nordisk cash inflow, and any setback on either front could quickly reshape sentiment.

    Find out about the key risks to this Omeros narrative.

    Next Steps

    Sentiment around Omeros is split, with clear upside hopes and real risk flags on the table. Move quickly, test the assumptions, and weigh both sides through the 4 key rewards and 4 important warning signs.

    Hunting For More Ideas Beyond Omeros?

    If you stop with just Omeros, you risk missing other setups that fit your style. Let the Simply Wall Street Screener surface fresh opportunities for you.